| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636179A1 Oil-body proteins as carriers of high-value peptides in plants |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636175A1 Decorin fragments and methods of inhibiting cell regulatory factors |
| 02/01/1995 | EP0636174A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636172A1 Genetically engineered attenuated viruses |
| 02/01/1995 | EP0636171A1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 02/01/1995 | EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
| 02/01/1995 | EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues |
| 02/01/1995 | EP0636030A1 pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | EP0473649B1 Biologically active polypeptides based on transforming growth factor-beta sequences |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 02/01/1995 | CN1098105A Novel material, dolastachin C and application of same |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386024 Method to prepare nucleic acids from a biological sample using low pH and acid protease |
| 01/31/1995 | US5386022 Primes and probes for the amplification and detection of aids associated nucleic acids |
| 01/31/1995 | US5386021 Mammalian guanine nucleotide binding protein with an ADP-rybosylation factor domain |
| 01/31/1995 | US5386014 Reducing and deoxygenating bovine hemoglobin; conjugation to activated polyalkylene oxide in presence of chloride anions |
| 01/31/1995 | US5386013 A polypeptide glycoprotein having hyaluronic acid binding activity; antiinflammatory, antiarthritic, anticancer agents, infections |
| 01/31/1995 | US5386011 Hexapeptide anaphylatoxin-receptor ligands |
| 01/31/1995 | US5385888 Class I MHC modulation or surface receptor activity |
| 01/31/1995 | US5385885 Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide |
| 01/31/1995 | US5385840 Respiratory system |
| 01/31/1995 | US5385831 Genetic engineering; culturing eukaryotic cells, isolating, purification; diagnosis, immunoassays, autoimmune diseases |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA2129156A1 High level expression of polypeptide that contains modified pres1 region of hepatitis b virus large antigen |
| 01/31/1995 | CA1334180C Antibiotics r106 |
| 01/27/1995 | CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
| 01/26/1995 | WO1995002825A1 Phosphate assay |
| 01/26/1995 | WO1995002823A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002701A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 01/26/1995 | WO1995002698A1 Composition and methods for transfecting eukaryotic cells |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002695A1 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 01/26/1995 | WO1995002694A2 Materials and methods for the control of calliphoridae pests |
| 01/26/1995 | WO1995002693A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002690A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 01/26/1995 | WO1995002688A1 Methods and compositions for the removal of viruses and uses thereof |
| 01/26/1995 | WO1995002687A1 Immortalized human fetal osteoblastic cells |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002684A1 Regulated apoptosis |
| 01/26/1995 | WO1995002611A1 Cell surface protein present on nk (natural killer cells) named dx1 |
| 01/26/1995 | WO1995002610A1 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 01/26/1995 | WO1995002608A1 Novel cholecystokinin and gastrin receptor ligands, production method therefor and pharmaceutical compositions containing same |
| 01/26/1995 | WO1995002423A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 01/26/1995 | WO1995002414A1 Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products |
| 01/26/1995 | WO1995002412A1 Antiallergic agent |
| 01/26/1995 | WO1995002324A1 Method of inactivation of viral and bacterial blood contaminants |
| 01/26/1995 | WO1994028126A3 Phenylalanine-free protein and dna coding therefor |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | WO1994028018A3 Synthetic sterically-constrained catalysts |
| 01/26/1995 | CA2167392A1 Methods and compositions for the removal of viruses and uses thereof |
| 01/26/1995 | CA2167282A1 Regulated apoptosis |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2167056A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 01/26/1995 | CA2166976A1 Method for identifying human and animal cells having an unlimited proliferation or tumor-formation potential |
| 01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
| 01/26/1995 | CA2166711A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | CA2165537A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635572A2 Biotin biosynthesis in bacillus subtilis |
| 01/25/1995 | EP0635518A1 New chondrocyte protein |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
| 01/25/1995 | EP0635064A1 Gustducin materials and methods |
| 01/25/1995 | EP0635062A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635059A1 Polysaccharide binding fusion proteins and conjugates |
| 01/25/1995 | EP0635057A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635055A1 $i(HAEMOPHILUS SOMNUS) IMMUNOGENIC PROTEINS |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
| 01/25/1995 | EP0635051A1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0635028A1 Pulmonary surfactant protein fragments |
| 01/25/1995 | EP0635027A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/25/1995 | EP0635025A1 Process for preparing modified proteins |
| 01/25/1995 | EP0635019A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
| 01/25/1995 | EP0635016A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 01/25/1995 | EP0635013A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| 01/25/1995 | EP0635000A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
| 01/25/1995 | EP0634999A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0634936A1 Materials and methods for immunocontraception |
| 01/25/1995 | EP0634935A1 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |